Beyond just peptide antigens: the complex world of peptide-based cancer vaccines

Beyond just peptide antigens: the complex world of peptide-based cancer vaccines

Peptide-based cancer vaccines rely upon the strong activation of the adaptive immune response to elicit its effector function. They have shown to be highly specific and safe, but have yet to prove themselves as an efficacious treatment for cancer in the clinic. This is for a variety of reasons, incl...

Full description

Bibliographic Details
Main Authors:	Stephens, AJ, Burgess-Brown, NA, Jiang, S
Format:	Journal article
Language:	English
Published:	Frontiers Media 2021

Similar Items

Beyond Just Peptide Antigens: The Complex World of Peptide-Based Cancer Vaccines
by: Alexander J. Stephens, et al.
Published: (2021-06-01)

Cancer-Testis Antigen Peptide Vaccine for Cancer Immunotherapy: Progress and Prospects
by: Xiao Wei, et al.
Published: (2019-05-01)

Adrenomedullin: Not Just Another Gastrointestinal Peptide
by: Sonia Martínez-Herrero, et al.
Published: (2022-01-01)

Prevention of EAE by tolerogenic vaccination with PEGylated antigenic peptides
by: Jennifer Pfeil, et al.
Published: (2021-08-01)

Peptide Vaccines for Cancer
by: Kono K
Published: (2013-10-01)

Peptide-Based Vaccine against SARS-CoV-2: Peptide Antigen Discovery and Screening of Adjuvant Systems
by: Ahmed O. Shalash, et al.
Published: (2022-04-01)

Adjuvants for peptide-based cancer vaccines
by: Willem W Overwijk, et al.
Published: (2016-09-01)

Peptide-based vaccine for cancer therapies
by: Luigi Buonaguro, et al.
Published: (2023-08-01)

Presentation of antigenic peptides by products of the major histocompatibility complex.
by: Fairchild, P
Published: (1998)

Developing recombinant overlapping peptides of prostate-specific antigen as vaccine
by: Chan, S
Published: (2022)

Role of Linker Length and Antigen Density in Nanoparticle Peptide Vaccine
by: Chintan H. Kapadia, et al.
Published: (2019-03-01)

Corrigendum: Peptide-based vaccine for cancer therapies
by: Luigi Buonaguro, et al.
Published: (2023-10-01)

Assessment of Crosslinkers between Peptide Antigen and Carrier Protein for Fusion Peptide-Directed Vaccines against HIV-1
by: Li Ou, et al.
Published: (2022-11-01)

1379 Novel backbone-modified analogues of antigenic peptides improve immunogenic capabilities of anti-tumor peptide vaccines
by: Douglas McNeel, et al.
Published: (2023-11-01)

Low-complexity sequences and single amino acid repeats: not just "junk" peptide sequences.
by: Haerty, W, et al.
Published: (2010)

TEIPP peptides: exploration of unTAPped cancer antigens
by: Koen A. Marijt, et al.
Published: (2019-08-01)

In vitro evaluation of dual-antigenic PV1 peptide vaccine in head and neck cancer patients
by: San Jiun Chai, et al.
Published: (2019-01-01)

Photochemical Internalization of Peptide Antigens Provides a Novel Strategy to Realize Therapeutic Cancer Vaccination
by: Markus Haug, et al.
Published: (2018-04-01)

Peptide Vaccine Therapy in Colorectal Cancer
by: Shi-Yu Yang, et al.
Published: (2012-08-01)

Peptide-Based Immunotherapeutics and Vaccines
by: Pedro A. Reche, et al.
Published: (2014-01-01)

Peptide-Based Vaccines for Tuberculosis
by: Wenping Gong, et al.
Published: (2022-01-01)

Potential association factors for developing effective peptide-based cancer vaccines
by: Chongming Jiang, et al.
Published: (2022-07-01)

Overlapping synthetic peptides as vaccines
by: Jiang, S, et al.
Published: (2006)

Computer-aided prediction of antigen presenting cell modulators for designing peptide-based vaccine adjuvants
by: Gandharva Nagpal, et al.
Published: (2018-07-01)

Peptide‐Based Cancer Vaccine Delivery via the STINGΔTM‐cGAMP Complex
by: He, Yanpu, et al.
Published: (2022)

Current Peptide and Protein Candidates Challenging HIV Therapy beyond the Vaccine Era
by: Koollawat Chupradit, et al.
Published: (2017-09-01)

Antigen presentation. Naturally processed peptides.
by: Elliott, T, et al.
Published: (1990)

Tolerogenic Immunomodulation by PEGylated Antigenic Peptides
by: Jennifer Pfeil, et al.
Published: (2020-10-01)

Beyond the vaccines: a glance at the small molecule and peptide-based anti-COVID19 arsenal
by: Kunal Nepali, et al.
Published: (2022-09-01)

1040-H Coupling DNA barcoding and multi-peptide screening: unveiling T cell receptor and antigenic peptide relationships in complex samples
by: Miranda Byrne-Steele, et al.
Published: (2023-11-01)

Synthetic peptide vaccines
by: O. V. Sergeyev, et al.
Published: (2016-02-01)

Peptide Vaccines for Leishmaniasis
by: Rory C. F. De Brito, et al.
Published: (2018-05-01)

Peptide-Based Immunotherapeutics and Vaccines 2017
by: Pedro Reche, et al.
Published: (2018-01-01)

Peptide-Based Immunotherapeutics and Vaccines 2015
by: Pedro Reche, et al.
Published: (2015-01-01)

Antitumor Peptide-Based Vaccine in the Limelight
by: Takumi Kumai, et al.
Published: (2022-01-01)

Editorial: Synthetic peptide vaccine platforms targeting tumor-specific antigens: advances and challenges
by: Reid M. Rubsamen, et al.
Published: (2024-02-01)

MHC-restricted antigen presentation and recognition: constraints on gene, recombinant and peptide vaccines in humans
by: Cunha-Neto E.
Published: (1999-01-01)

Light control of the peptide-loading complex synchronizes antigen translocation and MHC I trafficking
by: Jamina Brunnberg, et al.
Published: (2021-03-01)

Chaperone-mediated MHC-I peptide exchange in antigen presentation
by: Jiansheng Jiang, et al.
Published: (2024-05-01)

Molecular characterization of antigen-peptide pulsed dendritic cells: immature dendritic cells develop a distinct molecular profile when pulsed with antigen peptide.
by: Amy X Yang, et al.
Published: (2014-01-01)